EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Halt Order Ignored: Dehradun Plant Runs 4 Months On - In July 2026, a joint inspection team from the Central Drugs Standard Control Organisation (CDSCO) and the Uttarakhand State Licensing Authority walked into a pharmaceutical plant in Dehradun’s Selaqui industrial area and recommended that all manufacturing stop immediately. Four months later, the plant is still operating, and there is no public record that anyone acted […]
What 80% Batch Release Delays Reveal About Indian Pharma Quality - Nearly four in five pharmaceutical manufacturing professionals in India say open investigations are holding up drug batch releases, according to a white paper released in early November 2026. The finding matters well beyond the factory floor: a batch that cannot be released on time is a batch that does not reach the market — and […]
India Drafts Instant Licence Suspension for Substandard Drugs - India’s Union Health Ministry has proposed a sweeping change to how the country handles substandard medicines: instead of issuing a show-cause notice first and suspending a manufacturing licence later, regulators would be able to suspend that licence immediately the moment a government laboratory declares a drug Not of Standard Quality (NSQ) on one of five […]
NPPA Cancer Drug Price List Nears 1,136 Entries Before Nov 9 - India’s cancer drug price reset enters its final week with a discrepancy that patients and buyers should understand before November 9, 2026. The National Pharmaceutical Pricing Authority (NPPA) has been updating its revised maximum retail price (MRP) schedule for non-scheduled anti-cancer medicines in rolling instalments — and the headline count the regulator cites publicly is […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us